{"count": 4, "results": [{"_id": "35082306", "pmid": 35082306, "pmcid": "PMC8792053", "title": "Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment", "journal": "Sci Rep", "authors": ["Kahnert K", "Andreas S", "Kellerer C", "Lutter JI", "Lucke T", "Yildirim Ö", "Lehmann M", "Seissler J", "Behr J", "Frankenberger M", "Bals R", "Watz H", "Welte T", "Trudzinski FC", "Vogelmeier CF", "Alter P", "Jörres RA", "COSYCONET Study Group"], "date": "2022-01-26T00:00:00Z", "doi": "10.1038/s41598-022-05276-x", "meta_date_publication": "2022 Jan 26", "meta_volume": "12", "meta_issue": "1", "meta_pages": "1435", "score": 50286.535, "text_hl": "While @<m>DISEASE_Emphysema</m> @DISEASE_MESH:D004646 @@@emphysema@@@ is considered to be linked to premature aging, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ is discussed as potential anti-aging medication. ", "citations": {"NLM": "Kahnert K, Andreas S, Kellerer C, Lutter JI, Lucke T, Yildirim Ö, Lehmann M, Seissler J, Behr J, Frankenberger M, Bals R, Watz H, Welte T, Trudzinski FC, Vogelmeier CF, Alter P, Jörres RA, COSYCONET Study Group. Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment Sci Rep. 2022 Jan 26;12(1):1435. PMID: 35082306", "BibTeX": "@article{35082306, title={Reduced decline of lung diffusing capacity in COPD patients with diabetes and metformin treatment}, author={Kahnert K and Andreas S and Kellerer C and Lutter JI and Lucke T and Yildirim Ö and Lehmann M and Seissler J and Behr J and Frankenberger M and Bals R and Watz H and Welte T and Trudzinski FC and Vogelmeier CF and Alter P and Jörres RA and COSYCONET Study Group}, journal={Sci Rep}, volume={12}, number={1}, pages={1435}}"}}, {"_id": "34033525", "pmid": 34033525, "title": "Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.", "journal": "Am J Respir Crit Care Med", "authors": ["Polverino F", "Wu TD", "Rojas-Quintero J", "Wang X", "Mayo J", "Tomchaney M", "Tram J", "Packard S", "Zhang D", "Cleveland KH", "Cordoba-Lanus E", "Owen CA", "Fawzy A", "Kinney GL", "Hersh CP", "Hansel NN", "Doubleday K", "Sauler M", "Tesfaigzi Y", "Ledford JG", "Casanova C", "Zmijewski J", "Konhilas J", "Langlais PR", "Schnellmann R", "Rahman I", "McCormack M", "Celli B"], "date": "2021-09-15T00:00:00Z", "doi": "10.1164/rccm.202012-4510OC", "meta_date_publication": "2021 Sep 15", "meta_volume": "204", "meta_issue": "6", "meta_pages": "651-666", "score": 50275.473, "text_hl": "@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@: Experimental and Clinical Evidence for a Potential Role in @<m>DISEASE_Emphysema</m> @DISEASE_MESH:D004646 @@@Emphysema@@@ Treatment.", "citations": {"NLM": "Polverino F, Wu TD, Rojas-Quintero J, Wang X, Mayo J, Tomchaney M, Tram J, Packard S, Zhang D, Cleveland KH, Cordoba-Lanus E, Owen CA, Fawzy A, Kinney GL, Hersh CP, Hansel NN, Doubleday K, Sauler M, Tesfaigzi Y, Ledford JG, Casanova C, Zmijewski J, Konhilas J, Langlais PR, Schnellmann R, Rahman I, McCormack M, Celli B. Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment. Am J Respir Crit Care Med. 2021 Sep 15;204(6):651-666. PMID: 34033525", "BibTeX": "@article{34033525, title={Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment.}, author={Polverino F and Wu TD and Rojas-Quintero J and Wang X and Mayo J and Tomchaney M and Tram J and Packard S and Zhang D and Cleveland KH and Cordoba-Lanus E and Owen CA and Fawzy A and Kinney GL and Hersh CP and Hansel NN and Doubleday K and Sauler M and Tesfaigzi Y and Ledford JG and Casanova C and Zmijewski J and Konhilas J and Langlais PR and Schnellmann R and Rahman I and McCormack M and Celli B}, journal={Am J Respir Crit Care Med}, volume={204}, number={6}, pages={651-666}}"}}, {"_id": "40498633", "pmid": 40498633, "title": "Post-COPD: Can Emphysema Be Repaired?", "journal": "Am J Respir Crit Care Med", "authors": ["Wells JM", "Krishnan JA", "Wade RC", "Kinney G", "Wise RA", "Neptune E", "Polverino F", "Hanania NA", "Moll M", "Königshoff M", "Chandra D", "Sciurba F", "Marchetti N", "San José Estépar R", "Diaz AA", "El-Kersh K", "Castro M", "Zhang Y", "Holbrook JT", "Sugar EA", "Kraft M", "Kaner RJ", "Make B", "Rennard S"], "date": "2025-06-11T00:00:00Z", "meta_date_publication": "2025 Jun 11", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50262.05, "text_hl": "Several approved medications targeting pathways involved in lung repair could be tested to treat @<m>DISEASE_Emphysema</m> @DISEASE_MESH:D004646 @@@emphysema@@@ (e.g., @CHEMICAL_Tretinoin @CHEMICAL_MESH:D014212 @@@all-trans retinoic acid@@@, @CHEMICAL_Thiazolidinediones @CHEMICAL_MESH:D045162 @@@thiazolidinediones@@@, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, non-steroidal anti-inflammatory drugs, and @CHEMICAL_Lithium @CHEMICAL_MESH:D008094 @@@lithium@@@). ", "citations": {"NLM": "Wells JM, Krishnan JA, Wade RC, Kinney G, Wise RA, Neptune E, Polverino F, Hanania NA, Moll M, Königshoff M, Chandra D, Sciurba F, Marchetti N, San José Estépar R, Diaz AA, El-Kersh K, Castro M, Zhang Y, Holbrook JT, Sugar EA, Kraft M, Kaner RJ, Make B, Rennard S. Post-COPD: Can Emphysema Be Repaired? Am J Respir Crit Care Med. 2025 Jun 11;():. PMID: 40498633", "BibTeX": "@article{40498633, title={Post-COPD: Can Emphysema Be Repaired?}, author={Wells JM and Krishnan JA and Wade RC and Kinney G and Wise RA and Neptune E and Polverino F and Hanania NA and Moll M and Königshoff M and Chandra D and Sciurba F and Marchetti N and San José Estépar R and Diaz AA and El-Kersh K and Castro M and Zhang Y and Holbrook JT and Sugar EA and Kraft M and Kaner RJ and Make B and Rennard S}, journal={Am J Respir Crit Care Med}}"}}, {"_id": "35512853", "pmid": 35512853, "title": "Metformin suppresses epithelial sodium channel hyperactivation and its associated phenotypes in a mouse model of obstructive lung diseases.", "journal": "J Pharmacol Sci", "authors": ["Nakashima R", "Nohara H", "Takahashi N", "Nasu A", "Hayashi M", "Kishimoto T", "Kamei S", "Fujikawa H", "Maruta K", "Kawakami T", "Eto Y", "Ueno-Shuto K", "Suico MA", "Kai H", "Shuto T"], "date": "2022-06-01T00:00:00Z", "doi": "10.1016/j.jphs.2022.03.002", "meta_date_publication": "2022 Jun", "meta_volume": "149", "meta_issue": "2", "meta_pages": "37-45", "score": 50250.406, "text_hl": "One possible modulator of @GENE_SCNN1A @GENE_20276 @@@ENaC@@@ is @GENE_PRKAB1 @GENE_5564 @@@AMP-activated protein kinase@@@ (@GENE_PRKAB1 @GENE_5564 @@@AMPK@@@), a key molecule that controls a wide variety of cellular signals; however, little is known about whether @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@, a clinically available @GENE_PRKAB1 @GENE_5564 @@@AMPK@@@ activator, has a protective role against @GENE_SCNN1A @GENE_20276 @@@ENaC@@@-associated @DISEASE_Chronic_Disease @DISEASE_MESH:D002908 @@@chronic pulmonary phenotypes@@@, such as @<m>DISEASE_Emphysema</m> @DISEASE_MESH:D004646 @@@emphysema@@@ and @DISEASE_Pulmonary_Heart_Disease @DISEASE_MESH:D011660 @@@pulmonary dysfunction@@@. ", "citations": {"NLM": "Nakashima R, Nohara H, Takahashi N, Nasu A, Hayashi M, Kishimoto T, Kamei S, Fujikawa H, Maruta K, Kawakami T, Eto Y, Ueno-Shuto K, Suico MA, Kai H, Shuto T. Metformin suppresses epithelial sodium channel hyperactivation and its associated phenotypes in a mouse model of obstructive lung diseases. J Pharmacol Sci. 2022 Jun;149(2):37-45. PMID: 35512853", "BibTeX": "@article{35512853, title={Metformin suppresses epithelial sodium channel hyperactivation and its associated phenotypes in a mouse model of obstructive lung diseases.}, author={Nakashima R and Nohara H and Takahashi N and Nasu A and Hayashi M and Kishimoto T and Kamei S and Fujikawa H and Maruta K and Kawakami T and Eto Y and Ueno-Shuto K and Suico MA and Kai H and Shuto T}, journal={J Pharmacol Sci}, volume={149}, number={2}, pages={37-45}}"}}]}